Skip to main content
. 2022 Apr 29;13:2361. doi: 10.1038/s41467-022-30084-2

Fig. 2. LC-HRMS analysis of DarApk produced in vivo, showing the extracted ion chromatograms (EICs) and MS spectra.

Fig. 2

a DarApk produced by coexpression with DarEpk carries a + 12 Da modification. Because heterologous expression in E. coli only produced obtained the truncated DarApk, the theoretically predicted signals corresponding to the unmodified DarApk were shown for comparison. See Supplementary Fig. 3 for the HR-MS/MS spectrum of DarApk(43-58)-1. b DarApk produced by coexpression with the C86A mutant of DarEpk is a truncated peptide (i.e., DarApk(1-48)), which lacks the core and follower regions.